Dec 05, 2014
Connecticut, Hartford, Medical Marijuana Program Board of Physicians, William Rubenstein, Yale Daily News
Recently, a petition to expand the list of qualifying conditions for Connecticut’s medical marijuana program was introduced to the Medical Marijuana Program Board of Physicians.
According to Yale Daily News:
Registered patients and medical representatives attended last Wednesday’s hearing in Hartford calling for four additional medical conditions to be legally treated through medical marijuana. Members of the public gave testimonies before the board petitioning for the recognition of each of the conditions — sickle cell disease, Tourette Syndrome, psoriasis arthritis and Post-Laminectomy Syndrome — a common issue following back surgery.
The meeting concluded with the proposal left unresolved, allowing for additional testimonies and materials to be submitted to the board before Dec. 12. Commissioner of Consumer Protection William Rubenstein said that the board’s next meeting in January will deliberate on the petitions and decide whether to add the conditions.
If the board approves these conditions, members must take further steps before the additions become formally recognized. Rubenstein noted that a letter of recommendation must be submitted by the board to the commissioner of Consumer Protection before another public hearing is held. The motion will be approved only after a regulations review by the general assembly, he said.
Having only just been implemented in September, Connecticut’s medical marijuana statute allows for members of the public to request other debilitating conditions be added to the original 11 eligible for medical marijuana. However, other states have similar policies that have already been amended to include additional medical maladies.
Now that Connecticut’s medical marijuana program is underway, the state’s lawmakers must approve the expansion of coverage so that patients with conditions that could be treated with the use of medical marijuana receive their medicine and symptomatic relief as well.